Tomato recall across 14 states over Salmonella concerns: Full list of affected products
The U.S. Food and Drug Administration (FDA) has issued a recall on tomatoes due to potential Salmonella contamination, affecting consumers in 14 states. This recall is linked to tomatoes supplied by Hanshaw & Capling Farms (H&C Farms), located in Immokalee, Florida. The tomatoes were distributed under different labels by two separate companies—Williams Farms Repack LLC and Ray & Mascari Inc.
Salmonella is one of the most common causes of fatal foodborne illness in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC). It can result in a range of symptoms. Some infected people will have no signs, whereas others will develop diarrhea, fever, and stomach pain. Most people will recover without treatment, but the bacteria can lead to potentially deadly outcomes, especially in high-risk groups, such as children under 5 and the elderly.
Recall Date: May 2, 2025
Distribution Dates: April 23–28, 2025
States Affected: Georgia, North Carolina, South Carolina
Product Details:
5×6 25lb H&C Farms label
6×6 25lb H&C Farms label
Combo 25lb
4×4 2-layer
4×5 2-layer
60ct 2-layer
60ct 18lb loose
XL 18lb loose
3ct trays (UPC: 0 33383 65504 8)
Lot Codes: R4467, R4470
What you should do: If you purchased any of the above products, do not consume them. Return them to the point of purchase for a full refund or discard them. For more details call Jason Breland at 843-866-7707 or 843-599-5154.
Recall Date: May 3, 2025
States Affected: Illinois, Indiana, Kentucky, Michigan, Missouri, Mississippi, New York, Ohio, Pennsylvania, Tennessee, Wisconsin
Product Details:
4 Count Vine Ripe Tomatoes in 20 oz plastic clamshells
UPC: 7 96553 20062 1
Lot Numbers: RM250424 15250B, RM250427 15250B
What you should do: Consumers who bought these tomatoes should not consume them. Instead, return the product to the store for a full refund or dispose of it. For more details, you can contact Ray & Mascari Inc by calling 317-637-0234.
Related: 180,000 Safety 1st car seats recalled over choking hazard—what parents need to know
Salmonella is a type of bacteria that can cause severe foodborne illness. According to the Mayo Clinic, the most common symptoms include:
Diarrhea (which may be bloody)
Fever
Nausea
Vomiting
Abdominal pain
In some cases, Salmonella infection can lead to more serious complications, such as:
Arterial infections
Endocarditis (inflammation of the heart lining)
Arthritis
Certain groups, including young children under 5, the elderly, and people with weakened immune systems, are at a higher risk for severe illness or complications.
How to Prevent Salmonella Infections
As per PIRG, about 14% of all food recalls in the U.S. last year were due to possible salmonella contamination.To reduce the risk of Salmonella infections, follow these simple steps:
Wash and sanitize all surfaces that have come into contact with potentially contaminated food.
Wash your hands thoroughly with soap and warm water after handling potentially contaminated food or sanitizing surfaces.
Avoid eating high-risk foods such as raw sprouts, especially if you are immunocompromised.
Prevent cross-contamination with pet food, ensuring that surfaces and utensils used with pet food are sanitized.
By taking these precautions, you can help protect yourself and your loved ones from Salmonella and other foodborne illnesses.
As of now, no illnesses have been reported in connection with either of the recalls. However, due to the serious nature of Salmonella contamination, consumers are urged to follow the recall instructions carefully.
If you have purchased any of the recalled tomatoes, follow these steps:
Do Not Consume: Do not eat the affected tomatoes.
Return or Discard: You can return the recalled products to the store where you purchased them for a full refund. If returning is not an option, discard the tomatoes safely.
Monitor Symptoms: If you experience symptoms of Salmonella infection (e.g., diarrhea, fever, abdominal pain), seek medical advice immediately.
For any questions or further information regarding the recall, consumers can contact the relevant companies using the contact details provided:
Williams Farms Repack LLC:
Phone: 843-866-7707 or 843-599-5154
Business Hours: Monday–Friday, 8:00 am–5:00 pm EST
Ray & Mascari Inc.:
Phone: 1-317-637-0234
Business Hours: Monday–Saturday, 6:00 am–5:00 pm EST
The tomatoes were sold in various sizes and packaging, and the following details apply to all affected products:
Lot Codes: The affected products carry the lot codes R4467 and R4470.
States Affected: The tomatoes were distributed across the South, Midwest, and parts of New York and Pennsylvania.
While no illnesses have been reported yet, consumers in the affected states are urged to dispose of or return the recalled tomatoes to ensure their safety. Salmonella is a serious health risk, and the FDA is closely monitoring the situation to prevent any further risks to public health. For more information, visit the FDA's website or contact the companies involved.
Related: Target recalls baby food over lead concerns—here's what parents should do
Source:
Range of symptoms. CDC. 2025. 'Foodborne Illness Source Estimates.'
Tomato recall. FDA. 2025. 'Williams Farms Repack LLC Recalls Tomatoes Due to Possible Salmonella Contamination.'
Salmonella symptoms. Mayo Clinic. 2025. 'Salmonella infection.'
Food recalls due to Salmonella. PIRG. 2025. 'Food for Thought 2025.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
5 hours ago
- Business Insider
Perspective Therapeutics commences recruitment for 212PbVMT-alpha-NET
Perspective Therapeutics (CATX) announced that alignment was reached with the U.S. Food and Drug Administration, FDA, to open the third dosing cohort of its ongoing Phase 1/2a clinical trial for 212PbVMT-alpha-NET in patients with unresectable or metastatic somatostatin receptor 2, SSTR2,-positive neuroendocrine tumors who have not received prior radiopharmaceutical therapies. Patients in Cohort 3 will receive up to four fixed administered doses of 212PbVMT-alpha-NET at 6 mCi every eight weeks if they weigh more than 60kg, or 100muCi/kg of body weight if they weigh less than or equal to 60kg. Observations of dose limiting toxicities, DLTs, in up to eight patients within 42 days of the first treatment cycle will be used to assess whether this cohort of patients have received maximum tolerated dose, MTD, or maximum feasible dose, MFD. Once a safety monitoring committee, SMC, has reviewed the data from these initial patients, it may recommend exploring alternative dosing and/or recruit more patients into Cohort 3. Confident Investing Starts Here:
New York Post
3 days ago
- New York Post
Bill Gates shares ‘next phase of Alzheimer's fight' as he speaks about his father's personal battle
Bill Gates is speaking out about his personal experience with Alzheimer's — and his hope for progress in fighting the disease. In an essay published this week on his blog at the Microsoft co-founder and tech billionaire, 69, reflected on the difficulty of spending another Father's Day without his dad, Bill Gates Sr. Advertisement The elder Gates passed away in 2020 at the age of 94 after battling Alzheimer's. 'It was a brutal experience, watching my brilliant, loving father go downhill and disappear,' Gates wrote in the blog post. Today, motivated by his own experience with the common dementia, Gates — who serves as chair of the Gates Foundation — is committed to working toward a cure for the common dementia, which currently affects more than seven million Americans, or one in nine people over 65. In his blog, Gates expressed optimism about the 'massive progress' being made in the fight against Alzheimer's and other dementias. Advertisement Last year, Gates said he visited Indiana University's School of Medicine in Indianapolis to tour the labs where teams have been researching Alzheimer's biomarkers. 5 Bill Gates (left) is speaking out about his personal experience with Alzheimer's — and his hope for progress in fighting the disease. Brian Ach 'I also got the opportunity to look under the hood of new automated machines that will soon be running diagnostics around the world,' he wrote. 'It's an exciting time in a challenging space.' One of the biggest breakthroughs in Alzheimer's research, according to Gates, is blood-based diagnostic tests, which detect the ratio of amyloid plaques in the brain. (Amyloid plaques, clumps of protein that accumulate in the brain, are one of the hallmarks of Alzheimer's.) Advertisement 'I'm optimistic that these tests will be a game-changer,' Gates wrote. 5 The elder Gates passed away in 2020 at the age of 94 after battling Alzheimer's. Bloomberg via Getty Images Last month, the U.S. Food and Drug Administration (FDA) approved the first blood-based test for patients 55 years and older, as Fox News Digital reported at the time. Traditionally, Gates noted, the primary path to Alzheimer's diagnosis was either a PET scan (medical imaging) or spinal tap (lumbar puncture), which were usually only performed when symptoms emerged. Advertisement The hope is that blood-based tests could do a better job of catching the disease early, decline begins. 5 Last month, the U.S. Food and Drug Administration approved the first blood-based test for patients 55 years and older, as Fox News Digital reported at the time. – 'We now know that the disease begins 15 to 20 years before you start to see any signs,' Gates wrote. 'A simple, accurate and easy-to-run blood test might one day make routine screening possible, identifying patients long before they experience cognitive decline,' he stated. Gates said he is often asked, 'What is the point of getting diagnosed if I can't do anything about it?' Start and end your day informed with our newsletters Morning Report and Evening Update: Your source for today's top stories Thanks for signing up! Enter your email address Please provide a valid email address. By clicking above you agree to the Terms of Use and Privacy Policy. Never miss a story. Check out more newsletters To that end, he expressed his optimism for the future of Alzheimer's treatments, noting that two drugs — Lecanemab (Leqembi) and Donanemab (Kisunla) — have gained FDA approval. 'Both have proven to modestly slow down the progression of the disease, but what I'm really excited about is their potential when paired with an early diagnostic,' Gates noted. Advertisement He said he is also hopeful that the blood tests will help speed up the process of enrolling patients in clinical trials for new Alzheimer's drugs. 5 The hope is that blood-based tests could do a better job of catching the disease early, decline begins. Monkey Business – To accomplish this, Gates is calling for increased funding for research, which often comes from federal grants. 'This is the moment to spend more money on research, not less,' he wrote, also stating that 'the quest to stop Alzheimer's has never had more momentum.' Advertisement 'There is still a huge amount of work to be done — like deepening our understanding of the disease's pathology and developing even better diagnostics,' Gates went on. 5 Microsoft Chairman Bill Gates, his wife Melinda, far left, his father Bill Gates Sr., and his step-mother Mimi Gates pose for a photo in 2007. AP Gates pointed out that when his father had Alzheimer's, it was considered a 'death sentence,' but that is starting to change. Advertisement 'I am blown away by how much we have learned about Alzheimer's over the last couple of years,' he wrote. 'I cannot help but be filled with a sense of hope when I think of all the progress being made on Alzheimer's, even with so many challenges happening around the world. We are closer than ever before to a world where no one has to watch someone they love suffer from this awful disease.'
San Francisco Chronicle
3 days ago
- San Francisco Chronicle
Children's cough syrup recalled nationwide over bacterial risk that ‘can cause death'
Medtech Products issued a nationwide recall of its Little Remedies Honey Cough Syrup after discovering a bacterium that can cause serious foodborne illness, according to a U.S. Food and Drug Administration advisory. The voluntary recall affects five lots of the syrup, sold in 4-fluid-ounce amber bottles and distributed in stores — including Walgreens, Target, CVS, and Safeway — and online between December 14, 2022, and June 4, 2025. The affected product bears the UPC 7-56184-10737-9 and includes lot numbers 0039 (exp. 11/2025), 0545 (01/2026), 0640 (02/2026), 0450 (05/2026), and 1198 (12/2026). The recall extends to all lots still within their expiration dates. The bacteria found in the cough syrup, Bacillus cereus, can cause two distinct types of gastrointestinal illness. One type leads to nausea, vomiting and stomach cramps within hours of ingestion. The other manifests later, often with diarrhea and abdominal discomfort. 'Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death,' the FDA warned.
